MODIFICATION TO HYPOGUARD ADVANCE BLOOD GLUCOSE MONITORING SYSTEM— 510(k) K031388
Substantially EquivalentHypoguard USA, Inc.
FDA 510(k) clearance K031388 for MODIFICATION TO HYPOGUARD ADVANCE BLOOD GLUCOSE MONITORING SYSTEM, Substantially Equivalent on 2003-05-22. Applicant: Hypoguard USA, Inc.. Device class: 2.
Clearance details
- Applicant
- Hypoguard USA, Inc.
- Product code
- Code CGA
- Device class
- Class 2
- Regulation
- 21 CFR 862.1345
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Edina, MN, US
Recent devices under product code CGA
view allMore clearances from Hypoguard USA, Inc.
view all- K053079 — ASSURE PRO BLOOD GLUCOSE MONITORING SYSTEM, MODEL 460001
- K051514 — ASSURE PRO BLOOD GLUCOSE MONITORING SYSTEM, MODEL 460002
- K041881 — ADVANCE MICRO-DRAW BLOOD GLUCOSE MONITORING SYSTEM, MODEL 411100
- K033851 — DIASCREEN REAGENT STRIPS FOR URINALYSIS, MODELS D122OO (2GK), D12100 (1K), D11100 (1G)
- K024347 — EXPRESS BLOOD GLUCOSE MONITORING SYSTEM
Adverse events under product code CGA
product code CGA- Death
- 2
- Malfunction
- 1,816
- Total
- 1,818
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.